Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results.
Quest Diagnostics reported adjusted EPS of $3.00 and revenue of $3.10 billion, above FactSet estimates of $2.87 and $3.05 billion, respectively. It raised its 2026 revenue guidance to $12.07 billion-$12.11 billion and adjusted EPS guidance to $11.25-$11.35.
Thermo Fisher reported Q3 revenue of $12.14 billion, up 9%, and adjusted EPS of $6.68, up 15%. It raised 2026 revenue guidance to $47.7–$48.2 billion and adjusted EPS guidance to $25.13–$25.43.
ESCO Technologies reported Q3 2026 sales growth of 14%, with adjusted EBIT margins up 90 basis points to 22%. It expects full-year adjusted EPS to increase 38% to 39% in 2026.
On Wednesday, Jabil (NYSE: JBL ) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Jabil Inc reported a strong finish to fiscal 2026 with Q4 revenue